These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4984016)

  • 21. Ophthalmological manifestations in segmental neurofibromatosis type 1.
    Ruggieri M; Pavone P; Polizzi A; Di Pietro M; Scuderi A; Gabriele A; Spalice A; Iannetti P
    Br J Ophthalmol; 2004 Nov; 88(11):1429-33. PubMed ID: 15489488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies.
    Cambiaghi S; Restano L; Caputo R
    Pediatr Dermatol; 2004; 21(2):97-101. PubMed ID: 15078345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibromatosis.
    Wander JV; Das Gupta TK
    Curr Probl Surg; 1977 Feb; 14(2):1-81. PubMed ID: 405178
    [No Abstract]   [Full Text] [Related]  

  • 24. Melanotic macules in Albright's syndrome and in neurofibromatosis.
    Benedict PH; Szabó G; Fitzpatrick TB; Sinesi SJ
    JAMA; 1968 Aug; 205(9):618-26. PubMed ID: 4969843
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnosis of Recklinghausen's neurofibromatosis].
    Mautner VF; Umnus-Schnelle S; Köppen J; Heise U
    Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1149-51. PubMed ID: 3134186
    [No Abstract]   [Full Text] [Related]  

  • 26. [Neurofibromatosis, gigantism and subperiostal hematoma. 2 cases with extensive subperiostal bone formation on the long bones].
    Kullmann L; Wouters HW
    Rev Chir Orthop Reparatrice Appar Mot; 1972; 58():Suppl 1:237-40. PubMed ID: 4263999
    [No Abstract]   [Full Text] [Related]  

  • 27. Recognizing an index case of type 1 neurofibromatosis.
    Pollack CV; Pender ES
    Am Fam Physician; 1992 Feb; 45(2):623-8. PubMed ID: 1739047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Letter: Cafe-au-lait spots and Recklinghausen's disease].
    Nolte B
    Hautarzt; 1974 Nov; 25(11):575-6. PubMed ID: 4216594
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurofibromatosis of lid and orbit in early childhood.
    Mortada A
    Bull Ophthalmol Soc Egypt; 1976; 69(73):587-93. PubMed ID: 829564
    [No Abstract]   [Full Text] [Related]  

  • 30. Knowledge without truth: screening for complications of neurofibromatosis type 1 in childhood.
    Listernick R; Charrow J
    Am J Med Genet A; 2004 Jun; 127A(3):221-3. PubMed ID: 15150769
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic, systemic, and other childhood conditions affecting the musculoskeletal system.
    Jacobs JC
    Curr Opin Rheumatol; 1989 Oct; 1(3):268-71. PubMed ID: 2701678
    [No Abstract]   [Full Text] [Related]  

  • 32. [Letter: Significance of achromic spots in the infant].
    Debard A; Richardet JM
    Nouv Presse Med; 1975 Oct; 4(33):2405. PubMed ID: 812056
    [No Abstract]   [Full Text] [Related]  

  • 33. The myth of six café-au-lait spots in the peripheral form of neurofibromatosis.
    Goodman RM; Tiron A; Katznelson AB; Zehavi C; Romano A; Levine G
    Neurofibromatosis; 1988; 1(1):54. PubMed ID: 3152529
    [No Abstract]   [Full Text] [Related]  

  • 34. Pediatric neurofibromatosis: review.
    Fienman NL
    Compr Ther; 1981 Nov; 7(11):66-72. PubMed ID: 6797780
    [No Abstract]   [Full Text] [Related]  

  • 35. [Central nervous manifestations of neurofibromatosis in children (author's transl)].
    Andler W; Roosen K
    Klin Padiatr; 1977 Nov; 189(6):463-6. PubMed ID: 414018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Degeneration of von Recklinghausen's neurofibromatosis in childhood].
    Strube HD; Hofmann S
    Monatsschr Kinderheilkd (1902); 1975 May; 123(5):395-7. PubMed ID: 815791
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurofibromatosis, gigantism and subperiosteal haematoma. Report of two children with extensive subperiosteal bone formation.
    Kullmann L; Wouters HW
    J Bone Joint Surg Br; 1972 Feb; 54(1):130-8. PubMed ID: 4622184
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationships between severities of dermatological, neurological, and bone manifestations in neurofibromatosis type 1.
    Hirayama A; Nobeyama Y; Asahina A
    J Dermatol; 2023 Dec; 50(12):1647-1649. PubMed ID: 37830394
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bone symptoms in Recklinghausen's disease].
    Lipets ME; Prokof'eva NM; Shibaeva LN
    Vestn Dermatol Venerol; 1982 Nov; (11):52-5. PubMed ID: 6818783
    [No Abstract]   [Full Text] [Related]  

  • 40. [Continuous clinical management of patients with neurofibromatosis type 1].
    Ohno K
    Nihon Rinsho; 2010 Jan; 68(1):131-5. PubMed ID: 20077805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.